The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Dolutegravir’s first bump in the road to global roll-out begs larger questions around women’s rights and access to contraceptives at the International AIDS Conference (AIDS 2018).
Men who don’t disclose same-sex sexual behaviour have different HIV transmission patterns compared to other men who have sex with men (MSM) and heterosexual men.
Violence and lack of resources mean refugees living with HIV face unique barriers to adhering to treatment.
Reassurance for women living with HIV as commonly prescribed HIV drug deemed as safe as other regimes.
New research highlights significant gaps in health outcomes for adolescents born with HIV across the world – but paints a hopeful picture for the future as treatment access expands.
Adolescent treatment non-adherence remains a major challenge in sub-Saharan Africa. Addressing structural barriers to care retention, such as violence, could be key.
Nearly one-fifth (19%) of all cancers among people living with HIV could have been avoided by not smoking according to a recent study among people living with HIV in North America.
With three in ten gay men living with HIV engaging in chemsex in the last year in the UK, understanding its association with the country’s HIV and STI epidemics is critical to put an end to new infections.
As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.
Low-level viraemia is linked to treatment failure, but we are failing to make best use of effective HIV treatment as a result of inadequate viral load monitoring.